Übersichtsarbeit
Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia
Recent Patents on CNS Drug Discovery · 2006
DOI: 10.2174/157488906775245336 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on CNS Drug Discovery, 2006. Verfasst von Kenji Hashimoto. Beteiligte Einrichtung: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp. Die Arbeit wurde bisher 28-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnimalsBenzamidesGlutamic AcidGlycineGlycine Plasma Membrane Transport ProteinsHumansPiperidinesSchizophrenia
Substanzen
2-chloro-N-((S)-phenyl((2S)-piperidin-2-yl)methyl)-3-trifluoromethyl benzamideBenzamidesGlycine Plasma Membrane Transport ProteinsPiperidinesSLC6A9 protein, humanGlutamic AcidGlycine
Autor:innen und Institutionen
- Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp
Zitieren
APA
Hashimoto, K. (2006). Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia. Recent Patents on CNS Drug Discovery. https://doi.org/10.2174/157488906775245336
Vancouver
Hashimoto K. Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia. Recent Patents on CNS Drug Discovery. 2006. doi:10.2174/157488906775245336
BibTeX
@article{Hashimoto2006,
author = {Hashimoto, Kenji},
title = {Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia},
journal = {Recent Patents on CNS Drug Discovery},
year = {2006},
doi = {10.2174/157488906775245336}
}
EUVIMED